[CA-125 - does this next biomarker have a chance to hope for an expectation of risk stratification in patients with heart failure?].
Zieliński
Tomasz
T
Klinika Niewydolnosci Serca Transplantologii, Instytut Kardiologii, Warszawa.
D015415:Biomarkers / Q000097:blood; D018394:CA-125 Antigen / Q000097:blood*; D006333:Heart Failure / Q000097:blood* / Q000145:classification / Q000175:diagnosis / Q000401:mortality*; D006801:Humans; D020097:Natriuretic Peptide, Brain / Q000097:blood; D010446:Peptide Fragments / Q000097:blood; D010996:Pleural Effusion / Q000097:blood; D011379:Prognosis; D011498:Protein Precursors / Q000097:blood; D018570:Risk Assessment / Q000379:methods*; D015996:Survival Rate
D015415:Biomarkers; D018394:CA-125 Antigen; D010446:Peptide Fragments; D011498:Protein Precursors; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain